标题
A multi-targeted approach to treating bone metastases
作者
关键词
Prostate cancer, Bone metastasis, Microenvironment, Targeted therapy, Ecotherapy
出版物
CANCER AND METASTASIS REVIEWS
Volume 33, Issue 2-3, Pages 545-553
出版商
Springer Nature
发表日期
2014-01-03
DOI
10.1007/s10555-013-9476-y
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
- (2013) Shahneen K. Sandhu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Clinical Development of Immunostimulatory Monoclonal Antibodies and Opportunities for Combination
- (2013) I. Melero et al. CLINICAL CANCER RESEARCH
- Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease
- (2013) Harrison et al. Cancer Management and Research
- Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial†
- (2012) M. Reck et al. ANNALS OF ONCOLOGY
- Disrupting the Networks of Cancer
- (2012) D. F. Camacho et al. CLINICAL CANCER RESEARCH
- Bevacizumab-based therapy in relapsed glioblastoma: rationale and clinical experience to date
- (2012) Olivier L Chinot Expert Review of Anticancer Therapy
- Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer
- (2012) Kenneth J. Pienta et al. INVESTIGATIONAL NEW DRUGS
- Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial
- (2012) David C. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
- (2012) Kim Margolin et al. LANCET ONCOLOGY
- The role of antiresorptive therapies in improving patient care in early and metastatic breast cancer
- (2011) Dulcinea Candelaria-Quintana et al. BREAST CANCER RESEARCH AND TREATMENT
- Tumor Cells and Tumor-Associated Macrophages: Secreted Proteins as Potential Targets for Therapy
- (2011) Marc Baay et al. Clinical & Developmental Immunology
- PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
- (2011) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- Denosumab for bone diseases: translating bone biology into targeted therapy
- (2011) Elena Tsourdi et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow
- (2011) Yusuke Shiozawa et al. JOURNAL OF CLINICAL INVESTIGATION
- Novel Therapies for Metastatic Castrate-Resistant Prostate Cancer
- (2011) F. Dayyani et al. JNCI-Journal of the National Cancer Institute
- The tyrosine kinase inhibitor dasatinib dysregulates bone remodeling through inhibition of osteoclasts in vivo
- (2010) Kate Vandyke et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Denosumab: Second Chapter in Controlling Bone Metastases or a New Book?
- (2010) Monica N. Fornier JOURNAL OF CLINICAL ONCOLOGY
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines
- (2008) Tanja D. de Gruijl et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance
- (2008) M. B. Meads et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now